1.14
price down icon5.00%   -0.06
after-market Dopo l'orario di chiusura: 1.15 0.01 +0.88%
loading

Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.77%
57.70
54.04 70.94 76.65 63.82
Operating Income/Loss
6.77%
-57.70
-54.04 -70.94 -76.65 -63.82
Nonoperating Income/Loss
29.16%
0.945
1.334 3.049 4.152 5.247
Income/Loss From Continuing Operations Before Tax
7.68%
-56.76
-52.71 -67.89 -72.49 -58.58
Income Tax Expense/Benefit
100.00%
-
0.025 0.105 0.053 0.125
Income/Loss From Continuing Operations After Tax
7.63%
-56.76
-52.73 -67.99 -72.55 -58.70
Net Income/Loss
7.63%
-56.76
-52.73 -67.99 -72.55 -58.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.09%
161.84
161.69 161.45 159.58 158.98
Diluted Average Shares
0.09%
161.84
161.69 161.45 159.58 158.98
Basic Earnings Per Share
6.06%
-0.35
-0.33 -0.42 -0.45 -0.37
Diluted Earnings Per Share
6.06%
-0.35
-0.33 -0.42 -0.45 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):